松鸡
发表于 2025-3-23 13:10:58
and ribavirin (R) which was associated with a low success rate in patients with the most common genotype 1 hepatitis C virus (HCV) infection (40–50%), significant treatment-limiting side effects, and a long (48-week) duration of treatment. The HCV protease inhibitor telaprevir (VX-950) was discover
avenge
发表于 2025-3-23 14:27:27
Yuwei Sun,Zheng Zheng,Huiyan Dongiviral agents, the only treatment option was a regimen of interferon and ribavirin. It was modestly effective with only ~40% of genotype 1 patients demonstrating sustained virologic response. It was also accompanied with severe side effects with flu-like symptoms and increased suicidal tendencies du
百科全书
发表于 2025-3-23 20:48:45
The Chinese Stock Market Volume IIse that was explored in the context of tripeptide carboxylic acid-based inhibitors. A cyclopropyl-acyl sulfonamide moiety was found to be the optimal element at the P.-P.’ interface enhancing the potency of carboxylic acid-based prototypes by 10- to >100-fold, dependent upon the specific background.
别炫耀
发表于 2025-3-24 01:28:25
http://reply.papertrans.cn/43/4202/420175/420175_14.png
有说服力
发表于 2025-3-24 06:26:31
International Organization for Migrationt of this disease, offering patients an excellent chance for a complete cure. Starting from inhibitors incorporating oxime-based P*-shelf moieties, a collaborative effort between Abbott Laboratories and Enanta Pharmaceuticals generated ABT-450 (paritaprevir, a component of Technivie™ and Viekira Pak
共同给与
发表于 2025-3-24 09:22:26
http://reply.papertrans.cn/43/4202/420175/420175_16.png
bromide
发表于 2025-3-24 14:22:09
From B to Non-B to C: The Hepatitis C Virus in Historical Perspectivesurface protein of the hepatitis B virus (HBV) and the first marker for any human hepatitis virus. Studies of transfusion-associated hepatitis made it evident that most cases were unrelated to HBV. The later discovery of the hepatitis A virus (HAV) made it apparent that non-B cases were also non-A l
Increment
发表于 2025-3-24 18:29:02
http://reply.papertrans.cn/43/4202/420175/420175_18.png
外露
发表于 2025-3-24 22:46:07
http://reply.papertrans.cn/43/4202/420175/420175_19.png
Recessive
发表于 2025-3-24 23:46:39
The Hepatitis C Virus Replicon System and Its Role in Drug Developmenthepatocellular carcinoma. The HCV genome was cloned molecularly in 1989, and around 25 years later, antiviral therapy has been established that eliminates the virus in more than 95% of infected individuals. To reach this goal, several hurdles had to be overcome, a major one having been the developme